Corrigendum: Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial
J Crohns Colitis
.
2017 Dec 4;11(12):1510.
doi: 10.1093/ecco-jcc/jjx052.
Authors
David T Rubin
1
,
Russell D Cohen
1
,
William J Sandborn
2
,
Gary R Lichtenstein
3
,
Jeffrey Axler
4
,
Robert H Riddell
5
,
Cindy Zhu
6
,
Andrew C Barrett
6
,
Enoch Bortey
6
,
William P Forbes
6
Affiliations
1
Inflammatory Bowel Disease Center, University of Chicago Medicine, USA.
2
Division of Gastroenterology, University of California [UC] San Diego and UC San Diego Health System, USA.
3
Division of Gastroenterology, Perelman School of Medicine of the University of Pennsylvania, USA.
4
Toronto Digestive Disease Associates, Canada.
5
Department of Pathology and Laboratory Medicine, Mt Sinai Hospital, Canada.
6
Salix Pharmaceuticals, USA.
PMID:
28453665
PMCID:
PMC5951008
DOI:
10.1093/ecco-jcc/jjx052
No abstract available
Publication types
Published Erratum